16 Apr, 2021 05:46 PM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased to announce that it has received a A$1,155,055 cash rebate from the Australian Federal Gover...read more
14 Apr, 2021 09:25 AM
The last few months have certainly been a very busy period, not only for Immutep but for our whole sector. I would like to take the opportunity in our newsletter to add a bit more colour to the sign...read more
08 Apr, 2021 07:52 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease and aut...read more
07 Apr, 2021 08:28 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease and aut...read more
23 Mar, 2021 08:25 AM
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), is an Australian listed company whose core business is holding minority investments along the cannabis value-chain in Australia, Canada and Eu...read more
19 Mar, 2021 09:43 AM
Highlights:
Ethics Approval received for IONIC-1 clinical trial, with trial to commence immediately in Australian hospitals
IONIC-1 to test combination of Veyonda® with blockbuster Bristol...read more
18 Mar, 2021 09:04 AM
Chimeric Therapeutics, a clinical stage cell therapy company, is pleased to announce the successful completion of the planned dosing of the first patient cohort (n=4) in the phase 1 dose escalation ...read more
16 Mar, 2021 08:17 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease and aut...read more
12 Mar, 2021 05:02 PM
S&P Dow Jones Indices announced today the changes in the S&P/ASX Indices, effective prior to the open of trading on March 22, 2021, as a result of the March quarterly review.
For more inf...read more
